Lisa Lynn Decker, Chief Business Officer at IGM Biosciences, Inc. (IGMS), sold 1,180 shares at $6.21 ($7K) on 2023-11-29, disclosed to the SEC on 2023-12-01.
Open-market sale of $7k IGMS by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| IGMS | SELL | 2025-03-18 | $6K | — | Filing → |
| IGMS | SELL | 2024-12-18 | $8K | — | Filing → |
| IGMS | SELL | 2024-09-17 | $11K | — | Filing → |